POLOPAN® 40 mg Capsules
Pantoprazole 40 mg
Therapeutic Class: Proton Pump Inhibitor (PPI)
Composition: Each capsule contains Pantoprazole 40 mg.
Mechanism of Action: Pantoprazole selectively inhibits the gastric H⁺/K⁺-ATPase (proton pump), thereby reducing gastric acid secretion.
Indications:
- Gastroesophageal Reflux Disease (GERD)
- Erosive Esophagitis
- Acid-related dyspepsia, when clinically indicated
- Pathological hypersecretory conditions, including Zollinger–Ellison syndrome
Dosage and Administration:** The usual adult dose for GERD-related erosive esophagitis is 40 mg once daily, as prescribed. The duration of treatment depends on the clinical condition and response.
**Contraindications:** Hypersensitivity to pantoprazole, substituted benzimidazoles, or any formulation ingredient.
**Precautions:** Use cautiously in patients with severe hepatic impairment. Persistent or alarm symptoms require medical evaluation. Long-term therapy should be medically supervised.
Adverse Effects:** Headache, abdominal pain, nausea, diarrhea, and flatulence.
**Drug Interactions:** May interact with rilpivirine-containing products and medicines whose absorption depends on gastric pH. Review concomitant medications before use.
**Storage:** Store below 30°C, in a dry place, protected from light and moisture. Follow the product label.
**Presentation:** Capsules containing Pantoprazole 40 mg.
**Note:** For oral use. Use under medical supervision.
Company: UNIMAX